Physician profile

Christopher Scott Davis

General Practice (Dentist) · Lexington, KY

NPI 1386702041

$916.78

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$465.96
Education$315.32

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Voco America INC. $361.25 2022-2024 Futurabond U, Admira Fusion X-Tra, Grandio So
Align Technology, INC. $315.32 2023 Itero
Dentsply Sirona INC $115.11 2019-2023 Suresmile
Planmeca USA, INC. $98.81 2023 Planmeca Promax
Henry Schein, INC. $14.25 2020
Philips North America LLC $12.04 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher Scott Davis

$916.78

in general payments reported 2019-2025

Years
2019-2024
Top company
Voco America INC.

https://glasscript.com/doctor/17067/christopher-scott-davis

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.